OBI Pharma Announces NT$ 1.5 Billion Capital Infusion

OBI Pharma, Inc. (GreTai Securities Market: 4174), announced a new round of financing amounting to NT$ 1.5 billion has been completed. This signals the beginning of a new era in OBI Pharma’s development. This capital increase resulted in the issuance of a total of 9,493,671 shares at an offer price of NT$158, for a total […]

This article is password protected.

To view the content, please enter your password in the field below